Not available
Quote | GlaxoSmithKline PLC (NYSE:GSK)
Last: | $39.53 |
---|---|
Change Percent: | 0.46% |
Open: | $39.4 |
Close: | $39.35 |
High: | $39.58 |
Low: | $39.3 |
Volume: | 1,708,649 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | GlaxoSmithKline PLC (NYSE:GSK)
2024-07-22 02:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-21 07:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Bristol-Myers Squibb - Investors Are Too Long-Term Focused Bristol-Myers Squibb Is A Bargain Now AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings Dividend Roundup: Gold...
Message Board Posts | GlaxoSmithKline PLC (NYSE:GSK)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $GSK News Article - Global pharma giants partner Singapore researchers to boost innovat | whytestocks | investorshangout | 12/06/2022 7:20:45 PM |
whytestocks: $GSK News Article - Spero Therapeutics Announces Closing of Exclusive License Agreement | whytestocks | investorshangout | 11/08/2022 1:30:52 PM |
whytestocks: $GSK News Article - 3 Dirt-Cheap Stocks That Could Soar 48% to 68%, According to Wall S | whytestocks | investorshangout | 10/07/2022 3:15:49 PM |
Post hoc analysis shows that biomarker correlates with | jondoeuk | investorshub | 09/13/2022 4:41:37 PM |
$GSK Total Debt is $22.11 Billion // $8.00 | BottomBounce | investorshub | 08/11/2022 1:02:19 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-22 02:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-17 08:00:00 ET GSK (NYSE: GSK) , a global healthcare powerhouse, has been on a transformative journey since CEO Emma Walmsley took the helm in 2017. Despite its shares badly underperforming the S&P 500 under her first few years as CEO (see graph below), Walmsley's am...
2024-07-11 23:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...